Sign in to view content

Analysis of Retinal Fluid and Vision Outcomes in the Archway Phase 3 Trial of the Port Delivery System With Ranibizumab (PDS) in Patients With nAMD

Arshad M. Khanani, MD, MA, FASRS

Video
Published 2021

Related

Pharmacokinetic Profile of the Port Delivery System With Ranibizumab: From PRN Refills in Phase 2 Ladder to Fixed 24-Week Refills In Phase 3 Archway
Dilsher S. Dhoot, MD
Annual Meeting Talks
2020
Neovascular ARMD With Subretinal Hemorrhage, Red-Free Photos - Stereo
James B. Soque, CRA, OCT-C, COA, FOPS
Retina Image Bank: Images of the Week
2014
Fluorescein Angiographic Evaluation of Peripheral Retinal Vasculature After Ranubizumab Injection for Type I Retinopathy of Prematurity
Clio Armitage Harper, MD
Annual Meeting Talks
2016

Category: AMD-Neovascular

See more